SCHEMBL22148652

SCHEMBL22148652

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-n2c3ccccc3c3ccccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
NR1I3 Q14994 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPY5R Q15761 1/20 0.35
ADORA3 P0DMS8 2/20 0.35
MAPT P10636 3/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
NPC1 O15118 1/20 0.34
XBP1 P17861 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NLRP3 Q96P20 1/20 0.34
DHODH Q02127 1/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148643 0.96 L3MBTL1 (0.38) MEN1KMT2ACYP1A1CYP1A2CYP1B1
SCHEMBL22148876 0.94 ALDH1A1 (0.39) MEN1KMT2ACYP1A1CYP1A2CYP1B1
SCHEMBL21889533 0.94 MEN1 (0.38) MEN1KMT2ACYP1A1CYP1A2CYP1B1
SCHEMBL30338772 0.94 MEN1 (0.38) MEN1KMT2ACYP1A1CYP1A2CYP1B1
SCHEMBL30561142 0.94 NLRP3 (0.38) MEN1KMT2ANR1I3L3MBTL1NPY5R
SCHEMBL31037675 0.90 ADORA3 (0.33) MEN1KMT2ACYP1A1CYP1A2CYP1B1
SCHEMBL30709396 0.90 NR1I3 (0.40) MEN1KMT2ANR1I3L3MBTL1ADORA3
SCHEMBL21888620 0.90 NLRP3 (0.40) MEN1KMT2ANR1I3L3MBTL1ADORA3
SCHEMBL21562748 0.90 DHODH (0.41) MEN1KMT2AL3MBTL1ADORA3MAPT
SCHEMBL21562741 0.90 NLRP3 (0.40) MEN1KMT2AL3MBTL1ADORA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 MEN1 2193/4885KMT2A 4367/4885CYP1A1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.